Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study

Hecht M, Hahn D, Wolber P, Hautmann M, Reichert D, Weniger J, Belka C, Bergmann T, Goehler T, Welslau MK, Hofmann D, Fietkau R (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Annals of Oncology Elsevier

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Munich DE

DOI: 10.1093/annonc/mdy287.020

Authors with CRIS profile

Markus Hecht Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie

Involved external institutions

SRH Wald-Klinikum Gera DE Germany (DE) Universitätsklinikum Regensburg DE Germany (DE) Merck KGaA DE Germany (DE) Klinikum Stuttgart DE Germany (DE) Klinikum Aschaffenburg DE Germany (DE) Onkozentrum Dresden/Freiberg DE Germany (DE) Medizinische Studiengesellschaft Nord-West GmbH DE Germany (DE) Universitätsklinikum Köln DE Germany (DE) Ludwig-Maximilians-Universität (LMU) DE Germany (DE)

How to cite

APA:

Hecht, M., Hahn, D., Wolber, P., Hautmann, M., Reichert, D., Weniger, J.,... Fietkau, R. (2018). Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study. In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.

MLA:

Hecht, Markus, et al. "Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study." Proceedings of the 43rd ESMO Congress (ESMO), Munich OXFORD: OXFORD UNIV PRESS, 2018.

BibTeX: Download